For press inquiries click here to contact us.
Forbes
Stealthy 10X Genomics Raises $55.5M To Beef Up DNA Sequencing
The Business Journals
Intarcia Announces $1B License Deal For Diabetes Pump
BioWorld
Intarcia, Servier Sign Potential $1B Deal For Exenatide Implant In Type 2 Diabetes
The Wall Street Journal
New Implantable Pump Could Cut Diabetes Treatments
Xconomy
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More
The Boston Globe
Intarcia Raises $200m To Advance Its Diabetes Drug
FierceBiotech
Investors Pump $200M Into Intarcia’s PhIII For Once-Yearly Diabetes Therapy
The Wall Street Journal
Medical-Device Company Ivantis Has Closed On $27 Million
The Wall Street Journal
Biotech Intarcia Raises $210M
Please see important disclaimers in the Terms section.
